NASDAQ:CRVS

Corvus Pharmaceuticals Stock Forecast

etoro logo Buy CRVS
*Your capital is at risk
$11.60
-0.0900 (-0.770%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of CRVS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add CRVS to Watchlist?
Some Reasons Why To Add CRVS:
  • +209.3% price growth over the last year
  • +58.5% YTD performance
  • Low bankruptcy risk (Altman Z-Score: 44.75)
PDF

Red day on Wednesday for Corvus Pharmaceuticals
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 13, 2026 Loss -26.77%

The Corvus Pharmaceuticals stock price fell by -0.770% on the last day (Wednesday, 3rd Jun 2026) from $11.69 to $11.60. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 3.87% from a day low at $11.36 to a day high of $11.80. The price has fallen in 6 of the last 10 days but is still up by 0.87% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -310 thousand shares and in total, 2 million shares were bought and sold for approximately $18.58 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $11.07 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -14.16% during the next 3 months and, with a 90% probability hold a price between $9.50 and $14.24 at the end of this 3-month period.

CRVS Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 0.87%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Corvus Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $12.29 and $14.42. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Corvus Pharmaceuticals stock

Corvus Pharmaceuticals finds support from accumulated volume at $11.50 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.440 between high and low, or 3.87%. For the last week, the stock has had daily average volatility of 4.97%.

Corvus Pharmaceuticals is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRVS) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Corvus Pharmaceuticals to open at $11.59, and during the day (based on 14 day Average True Range), to move between $11.13 and $12.07, which gives a possible trading interval of +/-$0.95 (+/-8.50%) up or down from last closing price. If Corvus Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 8.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.50 (0.86%) than the resistance at $12.31 (6.12%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Corvus Pharmaceuticals stock A Buy?

Corvus Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.845 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $11.59 ( 0.115%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

CRVS Performance

Trading levels for CRVS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 12.03 3.68%
R2 11.86 2.23%
R1 11.75 1.33%
Price 11.60
S1 11.42 -1.56%
S2 11.31 -2.46%
S3 11.15 -3.91%

Accumulated Volume Support & Resistance Levels

Level Price
R3 13.66 17.72%
R2 13.33 14.91%
R1 12.31 6.12%
Price 11.60
S1 11.50 -0.86%
S2 0 -
S3 0 -

FAQ

What is the symbol for Corvus Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Corvus Pharmaceuticals is CRVS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Corvus Pharmaceuticals Stock?
Corvus Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Corvus Pharmaceuticals Stock?
Corvus Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Corvus Pharmaceuticals Stock.

What's the current price of Corvus Pharmaceuticals Stock?
As of the end of day on the Jun 03, 2026, the price of an Corvus Pharmaceuticals (CRVS) share was $11.60.

What is the 52-week high and low for Corvus Pharmaceuticals Stock?
The 52-week high for Corvus Pharmaceuticals Stock is $26.95 and the 52-week low is $3.56.

What is the market capitalization of Corvus Pharmaceuticals Stock?
As of the Jun 03, 2026, the market capitalization of Corvus Pharmaceuticals is 983.017M.

When is the next earnings date for Corvus Pharmaceuticals?
The upcoming earnings date for Corvus Pharmaceuticals is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT CORVUS PHARMACEUTICALS
Corvus Pharmaceuticals
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The company also develops CPI-818, a covalent inhibitor of ITK, which is in Phase I/Ib clinical trial to treat pa...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE